✦ LIBER ✦

Disposition of abouthiouzine: a novel antihyperthyroid drug

✍ Scribed by Khalid M. Alkharfy; Rao Muzaffar A. Khan; Badraddin M. Al-Hadiya; Hisham S. Abou-Auda; Rafiq R. Abou-Shaaban

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 114 KB
Volume: 28
Category: Article
ISSN: 0142-2782
DOI: 10.1002/bdd.536

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Disposition of CS-670, a novel nonsteroi

Disposition of CS-670, a novel nonsteroidal anti-inflammatory drug, and its metabolites in healthy human volunteers

✍ Masato Asami; Akemi Shigeta; Yorihisa Tanaka 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 588 KB

CS-670, a novel nonsteroidal anti-inflammatory drug, is a racemic prodrug. Plasma concentrations and urinary excretion of CS-670 and its metabolites were determined in experimental subjects after oral administration at a single 120 mg dose. CS-670 and four metabolites, the saturated ketone (M-A), un

Metabolism and disposition of EXP631—A n

Metabolism and disposition of EXP631—A novel antidepressant analgesic

✍ Y. N. Wong; D. L. Burcham; S.-M. Huang; C. Y. Quon 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 509 KB

## Abstract EXP631, 4‐(3‐thienyl)‐α,α, 1‐trimethyl‐4‐piperidinemethanol hemi‐fumarate salt (I), is a centrally acting non‐opioid analgesic compound with monoamine uptake blocking properties. EXP631 has analgesic effects in several animal models. It is intended to be used for the treatment of modera

Stereoselective disposition and chiral i

Stereoselective disposition and chiral inversion of KE-298, a new antirheumatic drug, in rats

✍ H. Yoshida; Y. Kohno; H. Endo; N. Ohmi; K. Fukushima; T. Suwa; M. Hayashi 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB 👁 2 views

The present study was an attempt to elucidate the relationship between stereoselective pharmacokinetics and protein binding of KE-298 and its active metabolites, deacetyl-KE-298 (M-1) and S-methyl-KE-298 (M-2). Metabolic chiral inversion was also investigated. The levels of unchanged KE-298 in plasm

A pharmacokinetic model for the percutan

A pharmacokinetic model for the percutaneous absorption of indomethacin and the prediction of drug disposition kinetics

✍ Taro Ogiso; Yoshimasa Ito; Masahiro Iwaki; Hidehiko Atago 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 497 KB

19F nuclear magnetic resonance imaging o

19F nuclear magnetic resonance imaging of drug distribution in vivo: The disposition of an antifolate anticancer drug in mice

✍ R. J. Maxwell; T. A. Frenkiel; D. R. Newell; C. Bauer; J. R. Griffiths 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 524 KB

The application of 19F nuclear magnetic resonance imaging to the study of drug distribution in vivo is discussed. CB3988 (C2-desamino-C2-methyl-N10-propargyl-2'-trifluoromethyl-5,8-dideazafolic acid) is a fluorinated representative of a class of quinazoline antifolates which act as inhibitors of thy

Deuterium labelling of the antidepressan

Deuterium labelling of the antidepressant drug doxepin for disposition studies in human subjects

✍ Chandra Prakash; Samir Saleh; Douglass F. Taber; Grant R. Wilkinson; Ian A. Blai 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 French ⚖ 528 KB

## Abstract Two methods have been developed for the introduction of deuterium into the doxepin molecule. The key intermediate (6,11‐dihydro‐1,2,3,4‐^2^H~4~‐dibenz[b,e]oxepin‐11‐one, 5) was prepared by condensation of ethyl 2‐bromomethylbenzoate with [^2^H~6~]‐phenol, saponification of the resulting